Healthtech Series B Investors & VC Firms
1216 firms in this list, with a median first check of $750K. 285 of them lead rounds. Generated from verified public data and updated continuously.
Finnish Fund for Industrial Cooperation Ltd. (FINNFUND)
HelsinkiSeed–Growth$2.7M – $135M
1 person
Fluke Venture Partners
KirklandSeed–Late Stage$1M – $4M
1 person
Alkemi Growth Capital
New Delhi, DelhiSeries A–Series B
4 people
Asclepius Life Sciences Fund, LP
New YorkSeed–Series B
4 people
Helsana HealthInvest AG
DübendorfSeed–Growth
4 people
Jumpstart Health Investors
NashvillePre-Seed–Late Stage
4 people
Lightspeed China Partners
ShanghaiSeed–Growth
10 people
Milkbox Partners
Seed–Late Stage
4 people
Tiantu Capital
ShenzhenSeed–Late Stage
4 people
UNIQA Ventures GmbH
ViennaSeed–Series B$1.1M – $5.4M
7 people
Linearis Ventures
Quebec CitySeed–Series B
3 people
LifeSci Venture Partners
New YorkSeries A–Late Stage
2 people
Wlanholding
ViennaSeed–Growth
1 person
Abbhi Capital
MiamiPre-Seed–Late Stage
Crescent Capital
BelfastSeed–Series B$571.5K – $1.5M
Healthcare Venture Partners, Llc
CharlestonSeries B–Late Stage
3 people
HealthQuad
IndiaSeed–Series C
3 people
Hotung Investment Holdings Ltd.
SingaporeSeries A–Late Stage$300K – $1.5M
Invest Northern Ireland
BelfastSeed–Late Stage
Sancor Seguros Ventures
SunchalesSeed–Growth$250K – $500K
Aescuvest
Frankfurt am MainSeed–Late Stage
1 person
Hillhouse Capital
ChangyangSeed–Series C$2.9M – $220M
Incipio Ventures
ZapopanPre-Seed–Growth
3 people
The Edgeof
SingaporeSeed–Growth
3 people
Related lists
Series B Investors & VC Firms (4094)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Series B Investors & VC Firms in United States (1625)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)
Data sourced from public filings and firms' own websites — see our methodology.





















